カプサイシンは,ミトコンドリアのオートファギーのPINK1/パーキン経路を通じて,HepG2における脂質代謝を調節する
Hao Song1, Minhao Xie2, Hui Xu1
1Collaborative Innovation Center for Modern Grain Circulation and Safety, and College of Food Science and Engineering, Nanjing University of Finance and Economics, Nanjing 210023, China.
Gene
|September 4, 2025
まとめ
チリペッパーに含まれるカプサイシンは,PINK1/パーキンミトファジー経路を活性化することによって,細胞の脂質蓄積を効果的に減少させます. このメカニズムは脂質代謝を調節し,代謝障害の治療に役立つ可能性があります.
科学分野:
- 生物化学
- 細胞生物学
- 薬理学について
背景:
- カプサイシン (CAP) は,チリペッパーから得られた天然の化合物で,特に脂質の減少という健康上の利点があることが示されています.
- カプサイシンの脂質低下作用の正確なメカニズムは完全に理解されていません.
- オレイン酸 (OA) は,HepG2細胞の脂質蓄積を誘導し,研究モデルとして機能する.
研究 の 目的:
- オレイン酸 (OA) 誘発の HepG2 細胞におけるカプサイシン (CAP) の脂質減少効果を調査する.
- 脂質代謝に対するCAPの作用の基礎となる分子メカニズムを解明する.
- CAPの効果におけるPINK1/パーキン媒介性ミトファギーの役割を探求する.
主な方法:
- 培養されたHepG2細胞は,脂質の蓄積を誘導するために,油酸 (OA) で処理された.
- 脂質濃度 (トリグリセリド,コレステロール) を分析した.
- 脂質代謝の調節体とPINK1/パーキン経路の遺伝子発現を評価し,Mdivi- 1とPINK- 1の遺伝子静止剤を用いてミトファギーを抑制した.
主要な成果:
- CAPはトライグリセリド,総コレステロール,およびLDL- Cを著しく低下させ,OA誘発のHepG2細胞におけるHDL- Cを増加させた.
- CAPは重要な脂質代謝遺伝子 (ACC,PPAR-α,PPAR-γ,Fasn,CPT-1,SREBP- 1C,SCD- 1) を調節している.
- CAPはPINK1/ パーキンミトファジー経路を活性化させ,これは抑制剤と遺伝子静止実験で確認されたように,脂質低下効果に不可欠でした.
結論:
- CAPはPINK1/パーキン信号伝達経路を活性化し,ミトファギーを促進することで脂質低下効果を発揮する.
- この活性化により細胞のエネルギーホメオスタシスが回復し,脂質合成と分解が調節されます.
- CAPは脂質代謝障害と肥満管理のための天然の治療薬としての可能性を示しています.
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Peroxisomes
14.3K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
14.3K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K


